• Users Online: 116
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2020  |  Volume : 4  |  Issue : 2  |  Page : 236-243

Comparison between topical cyclosporine A 0.05% and oral antioxidant in the treatment of dry eye disease


1 Profossor of Ophthalmology, Faculty of Medicine, Al-Azhar University, Egypt
2 Lecturer of Ophthalmology, Faculty of Medicine, Al-Azhar University, Egypt
3 Assistant Professor of Pathology Faculty of Medicine, Al-Azhar University, Egypt
4 Residant of Ophthalmology, Egypt

Correspondence Address:
MD Nermien Salah El-Dien Mohammed EL-Haddad
Department of Ophthalmology, Faculty of Medicine for Girls, Al-Azhar University, Cairo
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjamf.sjamf_40_20

Get Permissions

Background Dry eye disease is a multifactorial ocular pathology characterized by corneal epithelial lesions, inflammation of ocular surface, and symptoms of discomfort, including irritation, itching, and burning eyes. Aim The aim of this work is to compare the effect of both topical cyclosporine A 0.05% and oral antioxidant with the preservative-free artificial tears in the treatment of dry eye. Patients and methods This is a prospective randomized comparative cross-sectional study that included 180 eyes. Schirmer I test, break-up time test (BUT), corneal fluorescein staining score, and impression cytology grade were done. Results The results showed that there was no significant difference between the cyclosporine and the antioxidant groups after 3 months of treatment in terms of BUT (P=0.245), corneal fluorescein staining score (P=0.9052), and impression cytology grade (P=0.526), and they were significantly different in terms of (P=0.012). In the preservative-free group, although there were highly significant improvements in schirmer I test, BUT, corneal fluorescein staining, and impression cytology grade after 3 months of treatment, the cyclosporine and the antioxidant groups showed highly significant improvement than the preservative-free group. Conclusion Both topical cyclosporine A 0.05% and oral antioxidant treatments are effective for the treatment of dry eye disorder. However, cyclosporine has better results.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed309    
    Printed32    
    Emailed0    
    PDF Downloaded39    
    Comments [Add]    

Recommend this journal